Key result
Wearable dual-bioimpedance sensor tracks continuous SBP within ~0.1 mmHg mean absolute error while lying.
Why the study?
Arterial pulse wave signals from wearable devices are often affected by contact pressure with the skin, limiting the accuracy and reliability of hemodynamic parameter quantification.
Does a contact pressure-guided wearable dual-channel bioimpedance device accurately and continuously measure blood pressure compared to a clinical-grade reference device in a healthy participant?
Does a contact pressure-guided wearable dual-channel bioimpedance device accurately and continuously measure blood pressure compared to a clinical-grade reference device in a healthy participant?
A novel wearable dual-channel bioimpedance device utilizing contact pressure guidance can accurately provide continuous cuffless blood pressure monitoring based on pulse wave velocity.
May support cuffless wearable BP monitoring; leaves open ambulatory validation before clinical use.
Wearable devices for continuous monitoring of arterial pulse waves have the potential to improve the diagnosis, prognosis, and management of cardiovascular diseases. These pulse wave signals are often affected by the contact pressure between the wearable device and the skin, limiting the accuracy and reliability of hemodynamic parameter quantification. Here, we report a continuous hemodynamic monitoring device that enables the simultaneous recording of dual-channel bioimpedance and quantification of pulse wave velocity (PWV) used to calculate blood pressure (BP). Our investigations demonstrate the effect of contact pressure on bioimpedance and PWV. The pulsatile bioimpedance magnitude reached its maximum when the contact pressure approximated the mean arterial pressure of the subject. We employed PWV to continuously quantify BP while maintaining comfortable contact pressure for prolonged wear. The mean absolute error and standard deviation of the error compared to the reference value were determined to be 0.1 ± 3.3 mmHg for systolic BP, 1.3 ± 3.7 mmHg for diastolic BP, and -0.4 ± 3.0 mmHg for mean arterial pressure when measurements were conducted in the lying down position. This research demonstrates the potential of wearable dual-bioimpedance sensors with contact pressure guidance for reliable and continuous hemodynamic monitoring.
No takes yet. Share an insight, caveat, or question.
Namkoong et al. (2023) studied Healthy human subject (n=1). Wearable dual-channel bioimpedance device with contact pressure sensors vs. Finapres NOVA (medical-grade continuous blood pressure monitor) was evaluated on Mean absolute error and standard deviation of error for continuous blood pressure estimation (lying down) (Mean absolute error of 0.1 ± 3.3 mmHg for SBP, 1.3 ± 3.7 mmHg for DBP, and -0.4 ± 3.0 mmHg for MAP). The wearable dual-bioimpedance sensor accurately tracked continuous blood pressure, yielding a mean absolute error of 0.1 ± 3.3 mmHg for systolic blood pressure in the lying down position.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: